Adelaide Research & Scholarship: Search

Search

Results 1-10 of 36 (Search time: 0.004 seconds).

previous
1
2
3
4
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2017	DNA barcoding reveals habitual clonal dominance of myeloma plasma cells in the bone marrow microenvironment	Hewett, D.; Vandyke, K.; Lawrence, D.; Friend, N.; Noll, J.; Geoghegan, J.; Croucher, P.; Zannettino, A.
	2006	Suppression of androgen receptor signaling in prostate cancer cells by an inhibitory receptor variant	Butler, L.; Centenera, M.; Neufing, P.; Buchanan, G.; Choong, C.; Ricciardelli, C.; Saint, K.; Lee, M.; Ochnik, A.; Yang, M.; Brown, M.; Tilley, W.
	2015	Neural crest cell-derived VEGF promotes embryonic jaw extension	Wiszniak, S.; Mackenzie, F.E.; Anderson, P.; Kabbara, S.; Ruhrberg, C.; Schwarz, Q.
	2019	OBI-3424, a novel AKR1c3-activated prodrug, exhibits potent efficacy against preclinical models of T-ALL	Evans, K.; Duan, J.X.; Pritchard, T.; Jones, C.D.; McDermott, L.; Gu, Z.; Toscan, C.E.; El-Zein, N.; Mayoh, C.; Erickson, S.W.; Guo, Y.; Meng, F.; Jung, D.; Rathi, K.S.; Roberts, K.G.; Mullighan, C.G.; Shia, C.S.; Pearce, T.; Teicher, B.A.; Smith, M.A.; et al.
	2019	Bcl-2 is a therapeutic target for hypodiploid b-lineage acute lymphoblastic leukemia	Diaz-Flores, E.; Comeaux, E.Q.; Kim, K.L.; Melnik, E.; Beckman, K.; Davis, K.L.; Wu, K.; Akutagawa, J.; Bridges, O.; Marino, R.; Wohlfeil, M.; Braun, B.S.; Mullighan, C.G.; Loh, M.L.
	2017	Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancer	Ponnusamy, S.; Coss, C.; Thiyagarajan, T.; Watts, K.; Hwang, D.-J.; He, Y.; Selth, L.; McEwan, I.; Duke, C.; Pagadala, J.; Singh, G.; Wake, R.; Ledbetter, C.; Tilley, W.; Moldoveanu, T.; Dalton, J.; Miller, D.; Narayanan, R.
	2019	Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma	Neubauer, H.A.; Tea, M.N.; Zebol, J.R.; Gliddon, B.L.; Stefanidis, C.; Moretti, P.A.B.; Pitman, M.R.; Costabile, M.; Kular, J.; Stringer, B.W.; Day, B.W.; Samuel, M.S.; Bonder, C.S.; Powell, J.A.; Pitson, S.M.
	2020	Stathmin levels alter PTPN14 expression and impact neuroblastoma cell migration	Po uha, S.T.; Le Grand, M.; Brandl, M.B.; Gifford, A.J.; Goodall, G.J.; Khew-Goodall, Y.; Kavallaris, M.
	2012	Myb-binding protein 1A (MYBBP1A) is essential for early embryonic development, controls cell cycle and mitosis, and acts as a tumor suppressor	Mori, S.; Bernardi, R.; Laurent, A.; Resnati, M.; Crippa, A.; Gabrieli, A.; Keough, R.; Gonda, T.; Blasi, F.; Plow, E.
	2014	Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma	Al-Ejeh, F.; Pajic, M.; Shi, W.; Kalimutho, M.; Miranda, M.; Nagrial, A.; Chou, A.; Biankin, A.; Grimmond, S.; Brown, M.; Khanna, K.